Shares of Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the six brokerages that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a hold rating and five have assigned a buy rating to the company. The average […]
HC Wainwright Reiterates Buy Rating for Ocular Therapeutix (NASDAQ:OCUL) themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
JMP Securities restated their market outperform rating on shares of Ocular Therapeutix (NASDAQ:OCUL – Free Report) in a report released on Tuesday morning, Benzinga reports. The brokerage currently has a $24.00 price objective on the biopharmaceutical company’s stock. Other equities research analysts also recently issued research reports about the stock. HC Wainwright reaffirmed a buy […]
Ocular Therapeutix (NASDAQ:OCUL – Get Free Report) is set to release its earnings data after the market closes on Monday, March 11th. Analysts expect Ocular Therapeutix to post earnings of ($0.28) per share for the quarter. Ocular Therapeutix Stock Down 3.8 % Shares of NASDAQ OCUL opened at $9.98 on Friday. The company’s 50-day simple […]
Ocular Therapeutix, Inc. (NASDAQ:OCUL – Get Free Report) major shareholder Summer Road Llc purchased 930,851 shares of Ocular Therapeutix stock in a transaction that occurred on Monday, February 26th. The stock was acquired at an average price of $7.52 per share, with a total value of $6,999,999.52. Following the transaction, the insider now owns 8,591,401 […]